Consequences of COVID-19 Pandemic Including Endocrine and Metabolic Impacts


Book Description

A pandemic is an epidemic that spreads globally. Coronavirus disease 2019 (COVID-19) caused a major pandemic that affected human health and activities around the world since the beginning of 2020 and became a major international emergency. Through multiple paths, COVID-19 pandemic influenced life at individual, familial, societal, and environmental levels and led to a global economic recession. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the disease. It invades the target cells by binding to angiotensin-converting enzyme 2 (ACE2). Endocrine and metabolic systems can be implicated in COVID-19 infection. Subjects with several comorbidities (e.g., hypertension, diabetes, and obesity) are more likely to be infected and are at a higher risk for complications and death from COVID-19. Wearing mask, social distancing, home confinement, and isolation have been recommended and implemented in several countries to curb the spread of the outbreak. Vaccination remains the best protective measure. Different vaccines are now available and have been used. The worldwide impact of COVID-19 pandemic may last several years.




Diabetes Complications, Comorbidities and Related Disorders


Book Description

This book provides the reader with comprehensive information on the interactions between diabetes and a wide range of comorbid conditions and on disease management in such patients. It has the aim of empowering health care providers in their daily battle against the disease and its consequences. Diabetes has been identified by WHO and the United Nations as a medical emergency because of the increase in its global prevalence, which may reach one billion in three to four decades if the trend remains unchanged. Despite improved care that is helping to prolong life, diabetes impacts substantially on the quality of life of those affected and kills or disables several million people each year. The disease is systemic because all organs, tissues, and cells suffer in the presence of hyperglycemia and are damaged by the diabetic milieu. Unfortunately, most patients with diabetes will consequently experience chronic diabetic complications. This book will be of value for all physicians and nurses who care for patients with diabetes and face the challenge of treating hyperglycemia and related acute and chronic complications.




Endocrine and Metabolic Disorders


Book Description

Bottom Line Information to Effectively Diagnose DisordersThe diagnosis, management, and clinical testing associated with old, traditional, and new endocrine disorders have seen numerous advances during the past 10 years since the publication of the previous edition of this bestselling resource. Updating its classic predecessor in content and format




Environmental Endocrinology


Book Description

From 11 to 15 July 1977 about 60 physiologists, endo crinologists, ecologists and other biologists from 14 countries convened at the University Montpellier for a symposium on Environmental Endocrinology. This meet ing was organized as a Satellite Symposium of the 27th International Congress of Physiological Sciences, Paris, 18-23 July 1977. This volume is a record of the com munications presented at the symposium. The objectives of the program were to examine the role of the endocrine system in a wide spectrum of adjustments and adaptations to changes in environmental conditions by various spe cies of animals, including man, and to promote an ex change of ideas among investigators who have approached these functions from diverse aspects. The diversity of the information and ideas communicated is great. Of necessity, they represent only an extremely modest se lection of the many facets of endocrine function in the interaction of animals with their environments. Be yond the usefulness of the communications individually, we hope that they collectively demonstrate the substan tial heuristic value of the concept of environmental endocrinology as it was perceived by the participants. We acknowledge gratefully the kindness and sympathy of Professor Jaques ROUZAUD, President of the University of Montpellier II, for his generous extension of the hospitality of the University to the Symposium. We are most grateful to Mrs. Monique VIEU who effected so well the secretarial organization of the Sympos.




Polymyalgia Rheumatica and Giant Cell Arteritis


Book Description

Part of the Oxford Rheumatology Library series, Polymyalgia Rheumatica and Giant Cell Arteritis provides quick and practically relevant information on several aspects of the diseases, particularly on diagnosis and management, with the ultimate aim of improving the patient's care.




COVID-19 and Diabetes: Current Findings and Future Perspectives


Book Description

Since the end of 2019, Coronavirus disease 2019 (COVID-19), which caused more than 6 million deaths worldwide, immediately gained attention as a major public health issue. The clinical spectrum of COVID-19 encompasses a wide range of conditions, from a minor upper respiratory tract infection to severe interstitial pneumonia with respiratory and even multi-organ failure and a high in-hospital mortality. This unpredictability encouraged the development of tailored vaccination tactics to control the viral propagation and slow the progression of the disease. During the pandemic, a vast amount of clinical and laboratory data was gathered, allowing researchers to learn more about the progression of the disease as well as the efficacy and safety of the anti-SARS-Cov-2 vaccine.




Endocrinology and Metabolic Diseases


Book Description

Endocrinology and metabolic diseases are an important area of study in any medical course. This fully indexed text covers the essentials of the subject in a succint and lucid fashion, and several hundred illustrations with numbered labels allow for quick revision.




Psychosocial Care for People with Diabetes


Book Description

Psychosocial Care for People with Diabetes describes the major psychosocial issues which impact living with and self-management of diabetes and its related diseases, and provides treatment recommendations based on proven interventions and expert opinion. The book is comprehensive and provides the practitioner with guidelines to access and prescribe treatment for psychosocial problems commonly associated with living with diabetes.




Diabetes in Children and Adolescents


Book Description

Currently, available information on pediatric and adolescent diabetes is limited to chapters in larger books covering the broader topic of pediatric endocrinology, and these do not have the space to delve into specific topics. This concise, timely book contains everything that a practicing provider needs to know in order to provide comprehensive, up-to-date care for children and adolescents with diabetes, from the latest methods for diagnosing various types of diabetes to integrating cutting-edge technology in the care of this patient population. Initial management, the use of insulin pumps, continuous glucose monitoring, and automated insulin delivery are discussed in detail, as are nutrition therapy, exercise, psychosocial challenges, acute and long-term complications, and future directions for treatment and research. Further, this book provides clinicians with guidelines for the implementation of best practices as outlined by leading associations such as the American Diabetes Association (ADA) and International Society of Pediatric and Adolescent Diabetes (ISPAD). The Yale Children’s Diabetes Program has been ranked among the best in the United States, including clinicians and researchers who are world-renowned for their efforts in improving the care of children with diabetes. This wealth of knowledge and experience positions the author team well as experts in this field.




Glucocorticoid-induced Osteoporosis


Book Description

Osteoporosis is one of the most clinically relevant disabling chronic disease encountered in clinical practice. A common cause of osteoporosis is glucocorticoid excess, as glucocorticoids may increase bone resorption, inhibit bone formation, have indirect actions on bone by decreasing intestinal calcium absorption and induce hypercalciuria. This book presents a comprehensive overview of the effects of glucocorticoids on bone metabolism and structure and on the diagnosis and treatment of glucocorticoid-induced osteoporosis. It aims at providing updated information on the pathogenesis, diagnosis and treatment of this often dramatic complication of glucocorticoid excess. Being one of the few publications completely devoted to glucocorticoid-induced osteoporosis it will heighten the awareness of specialists who prescribe glucocorticoids of the clinical relevance of this treatment complication. 'Glucocorticoid-Induced Osteoporosis' is addressed to clinical experts as well as to general practitioners who will both benefit from the comprehensive and integrative view of the management of patients exposed to glucocorticoids.